Loading
NASDAQHealthcareMedical - Instruments & Supplies
Latest quote
$8.24
+$0.11 · +1.35%
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
Previous close
$8.24
+$0.11 · +1.35%
Regular session · ET · Market data may be delayed.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
Day range
Current $8.24
52-week range
Current $8.24
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
46
Fair Value
Sentiment
51
Mixed
Risk
67
High Risk
Momentum
44
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
Day range
Current $8.24
52-week range
Current $8.24
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 86.55M USD | 94.14M USD | 112.25M USD | 113.34M USD | 118.9M USD |
| Cost of goods sold | 40.67M USD | 39.37M USD | 46.18M USD | 52.52M USD | 51.25M USD |
| Gross profit | 45.88M USD | 54.77M USD | 66.07M USD | 60.82M USD | 67.65M USD |
| Research and development | 8.83M USD | 10.41M USD | 11.76M USD | 12.33M USD | 10.8M USD |
| Selling, general, and administrative | 36.96M USD | 43.71M USD | 46.89M USD | 49.53M USD | 48.95M USD |
| Operating expenses | 46.51M USD | 60.98M USD | 64.18M USD | 67.75M USD | 65.59M USD |
| Interest expense | 4.92M USD | 3.21M USD | 3.59M USD | 2.55M USD | 1.54M USD |
| Depreciation and amortization | 5.95M USD | 7.16M USD | 7M USD | 7.58M USD | 7.62M USD |
| Operating income | −629K USD | −6.21M USD | 1.89M USD | −6.93M USD | 2.07M USD |
| Net income | −56.7M USD | −12.41M USD | −3.42M USD | −9.52M USD | −288K USD |
Company facts updated Oct 10, 2026.
Third-party consensus; not a GoAI recommendation.
Average target
$38.00
361.17% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Mar 16, 2026 | 1:10 | — | — |
Stock split | Nov 4, 2013 | 1,319:1,000 | — | — |
Effective Mar 16, 2026
1:10
Effective Nov 4, 2013
1,319:1,000
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI1M0.00%2.3T USD0.03%$381.94+0.63%
Vanguard Extended Market ETFVXF340.97K0.00%95.4B USD0.05%$235+0.80%
Dimensional - US Sustainability Core 1 ETFDFSU15.46K0.00%2.39B USD0.15%$48.11+0.48%
Dimensional - US Small Cap ETFDFAS13.2K0.00%33.87B USD0.31%$78.35+0.32%
U.S. Vector Equity Portfolio ETF Class SharesDXUV9.99K0.00%6.18B USD0.26%$68.28+0.25%
Dimensional - US Core Equity 2 ETFDFAC8.37K0.00%88.6B USD0.21%$45.33+0.49%
U.S. Core Equity 1 Portfolio ETF Class SharesDCOR7.54K0.00%45.59B USD0.17%$84.44+0.44%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFDimensional - US Sustainability Core 1 ETFDFSUDimensional - US Small Cap ETFDFASU.S. Vector Equity Portfolio ETF Class SharesDXUVDimensional - US Core Equity 2 ETFDFACU.S. Core Equity 1 Portfolio ETF Class SharesDCORAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
